Silexion Therapeutics (SLXN) Assets (2023 - 2026)
Silexion Therapeutics (SLXN) posted quarterly Assets of $4.6 million for Q1 2026, down 44.61% year-over-year from $8.3 million in Q1 2025, and down 36.22% quarter-over-quarter from $7.2 million in Q4 2025.
Silexion Therapeutics (SLXN) Assets (2023 - 2026) Analysis & Trends
Silexion Therapeutics' Assets history runs 4 years deep, the most recent figure standing at $4.6 million for Q1 2026.
- In Q1 2026, Assets fell 44.61% year-over-year to $4.6 million; the TTM figure through Mar 2026 stood at $4.6 million (down 44.61% YoY), while the FY2025 annual figure was $7.2 million, up 152.01% from the prior year.
- Assets for Q1 2026 stood at $4.6 million, down from $7.2 million in the prior quarter.
- The five-year high for Assets was $11.6 million in Q3 2025, with the low at $2.3 million in Q2 2024.
- The 4-year median for Assets is $4.9 million (2023), against an average of $5.5 million.
- The sharpest annual moves came in 2024 and 2025: Assets plunged 45.53% in 2024, then soared 276.22% in 2025.
- Silexion Therapeutics' Assets stood at $5.3 million in 2023, then plunged by 45.53% to $2.9 million in 2024, then soared by 152.01% to $7.2 million in 2025, then plunged by 36.22% to $4.6 million in 2026.
- Business Quant data shows SLXN's Assets at $4.6 million in Q1 2026, $7.2 million in Q4 2025, and $11.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.79 Bn | 130.93 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 78.00 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 56.04 Bn | 50.91 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.05 Bn | 36.95 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.71 Bn | 28.40 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 27.66 Bn | 9.26 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.50 Bn | 26.33 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - | 19.82 Bn |
| 10 | Silexion Therapeutics | 267,449.04 | -1.96 Mn | - | 4.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.25 Mn |
| Mar 31, 2026 | 4.60 Mn |
| Dec 31, 2025 | 7.22 Mn |
| Sep 30, 2025 | 11.61 Mn |
| Jun 30, 2025 | 5.80 Mn |
| Mar 31, 2025 | 8.31 Mn |
| Dec 31, 2024 | 2.86 Mn |
| Sep 30, 2024 | 3.09 Mn |
| Jun 30, 2024 | 2.32 Mn |
| Mar 31, 2024 | 3.59 Mn |
| Dec 31, 2023 | 5.26 Mn |